论著 · 基础研究

HENMT1通过激活PI3K-AKT-mTOR信号通路促进胃癌的增殖与迁移

  • 杨娜 ,
  • 刘俊丽 ,
  • 白静 ,
  • 杨思怡 ,
  • 韩继明 ,
  • 张华华
展开
  • 延安大学延安医学院,延安 716000
杨 娜(1981—),女,硕士生;电子信箱:1059399940@qq.com
第一联系人:杨娜负责实验设计和实验操作,刘俊丽负责实验操作和生物信息学分析,白静、杨思怡负责实验材料的准备和数据分析,杨娜、张华华负责论文的撰写和校正,韩继明、张华华负责课题的监管和指导。所有作者均阅读并同意最终稿件的提交。
张华华,实验师,硕士;电子信箱:yadxzhh@yau.edu.cn

收稿日期: 2024-10-24

  录用日期: 2025-04-28

  网络出版日期: 2025-06-28

基金资助

国家自然科学基金(82060521);陕西省自然科学基础研究计划项目(2024JC-YBMS-683);陕西省教育厅专项科研计划项目(23JK0735);2024年陕西省大学生创新创业训练计划项目(S202410719136)

HENMT1 promotes the proliferation and migration of gastric cancer by activating the PI3K-AKT-mTOR signaling pathway

  • YANG Na ,
  • LIU Junli ,
  • BAI Jing ,
  • YANG Siyi ,
  • HAN Jiming ,
  • ZHANG Huahua
Expand
  • Yan'an Medical College of Yan'an University, Yan'an 716000, China
First author contact:The study design and experiments were completed by YANG Na. Experiments and bioinformatics analyses were performed by LIU Junli. The preparation of experimental materials and data analysis were carried out by BAI Jing and YANG Siyi. The manuscript was drafted and revised by YANG Na and ZHANG Huahua. Project supervision and guidance were provided by Han Jiming and Zhang Huahua. All authors have read the last version of paper and consented to submission.
ZHANG Huahua, E-mail: yadxzhh@yau.edu.cn.

Received date: 2024-10-24

  Accepted date: 2025-04-28

  Online published: 2025-06-28

Supported by

National Natural Science Foundation of China(82060521);Basic Research Program in Natural Sciences of Shaanxi Province(2024JC-YBMS-683);Special Scientific Research Program of Shaanxi Provincial Education Department(23JK0735);2024 Shaanxi College Students Innovation and Entrepreneurship Training Program(S202410719136)

摘要

目的·探究HEN甲基转移酶1(HEN methyltransferase 1,HENMT1)在胃癌(gastric cancer,GC)增殖和迁移中的作用及潜在的分子机制。方法·利用生物信息学数据库、Western blotting和实时荧光定量PCR(quantitative real-time PCR,qPCR)检测HENMT1在GC中的表达。使用Kaplan-Meier Plotter和BEST在线分析HENMT1表达与临床GC患者总生存期、神经侵袭、亚型、肿瘤发生部位及Lauren分型的相关性。体外培养胃癌细胞,采用靶向HENMT1的小干扰RNA(small interfering RNA,siRNA)及其过表达载体联合PI3K激活剂(740 Y-P)和PI3K抑制剂(3-MA)处理胃癌细胞,通过细胞计数试剂盒8(cell counting kit-8,CCK-8)实验、克隆形成实验、细胞划痕实验以及Transwell迁移实验,检测HENMT1在胃癌细胞增殖及迁移中的作用。结果·HENMT1在GC中的表达显著升高,且其高表达与神经侵袭呈正相关;HENMT1的表达与GC的亚型密切相关,在增殖型中最为显著;在Lauren分型中的肠型胃癌表达更高。HENMT1的表达与患者的总生存期和GC发生部位(如胃体、贲门、胃窦和全胃)无明显相关性。功能实验结果表明,沉默HENMT1能够抑制胃癌细胞的增殖和迁移能力,而过表达HENMT1则促进这些功能。进一步的机制研究发现,沉默HENMT1导致PI3K-AKT-mTOR信号通路关键蛋白p-PI3K、p-AKT和p-mTOR水平下降,同时PI3K、AKT和mTOR的总蛋白表达也降低;相反,过表达HENMT1则使这些蛋白的表达上调。此外,siHENMT1联合PI3K激活剂740 Y-P能够有效逆转740 Y-P诱导的胃癌细胞增殖和迁移效应,而over-HENMT1联合3-MA则能够有效逆转3-MA抑制的胃癌细胞增殖和迁移作用。结论·HENMT1在GC中呈高水平表达,并通过激活PI3K-AKT-mTOR信号通路正向调控胃癌细胞的增殖与迁移能力。

本文引用格式

杨娜 , 刘俊丽 , 白静 , 杨思怡 , 韩继明 , 张华华 . HENMT1通过激活PI3K-AKT-mTOR信号通路促进胃癌的增殖与迁移[J]. 上海交通大学学报(医学版), 2025 , 45(6) : 717 -726 . DOI: 10.3969/j.issn.1674-8115.2025.06.006

Abstract

Objective ·To investigate the role of HEN methyltransferase 1 (HENMT1) in the proliferation and migration of gastric cancer (GC) and its potential molecular mechanisms. Methods ·The expression of HENMT1 in GC was examined using bioinformatics databases, Western blotting and quantitative real-time PCR (qPCR). Kaplan-Meier Plotter and BEST online tools were used to analyze the correlations between HENMT1 expression and overall survival, perineural invasion, subtypes, tumor location and Lauren classification in clinical GC patients. GC cells were cultured in vitro and treated with small interfering RNA (siRNA) targeting HENMT1 and HENMT1 overexpression vectors, in combination with a PI3K activator (740 Y-P) or PI3K inhibitor (3-MA). The roles of HENMT1 in GC cell proliferation and migration were assessed using cell counting kit-8 (CCK-8) assay, colony formation assay, wound healing assay and Transwell migration assay. Results ·HENMT1 was significantly upregulated in GC and positively associated with perineural invasion. Its expression was closely related to GC subtypes, being most pronounced in the proliferative subtype, and was higher in intestinal-type GC according to the Lauren classification. However, HENMT1 expression showed no significant correlation with overall survival or tumor location (including gastric body, cardia, antrum and whole stomach). Functional experiments demonstrated that silencing HENMT1 inhibited GC cell proliferation and migration, whereas overexpression of HENMT1 enhanced these capabilities. Mechanistically, silencing HENMT1 reduced the levels of phosphorylated PI3K, AKT and mTOR, as well as their total protein expression. Conversely, HENMT1 overexpression upregulated these proteins. Moreover, siHENMT1 combined with the PI3K activator 740 Y-P effectively reversed the proliferation and migration effects induced by 740 Y-P, while overexpressed HENMT1 combined with the PI3K inhibitor 3-MA reversed the suppressive effects of 3-MA on GC cell proliferation and migration. Conclusion ·HENMT1 is highly expressed in GC and positively regulates the proliferation and migration of gastric cancer cells by activating the PI3K-AKT-mTOR signaling pathway.

参考文献

[1] YAN L J, CHEN Y, CHEN F, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up[J]. Gastroenterology, 2022, 163(1): 154-162.e3.
[2] ZHENG R S, ZHANG S W, ZENG H M, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
[3] XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.
[4] FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.
[5] FENG R M, ZONG Y N, CAO S M, et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics?[J]. Cancer Commun (Lond), 2019, 39(1): 22.
[6] BILLI A C, ALESSI A F, KHIVANSARA V, et al. The Caenorhabditis elegans HEN1 ortholog, HENN-1, methylates and stabilizes select subclasses of germline small RNAs[J]. PLoS Genet, 2012, 8(4): e1002617.
[7] HUANG R H. Unique 2'-O-methylation by Hen1 in eukaryotic RNA interference and bacterial RNA repair[J]. Biochemistry, 2012, 51(20): 4087-4095.
[8] LIM S L, QU Z P, KORTSCHAK R D, et al. HENMT1 and PiRNA stability are required for adult male germ cell transposon repression and to define the spermatogenic program in the mouse[J]. PLoS Genet, 2015, 11(10): e1005620.
[9] 戴馨缘, 王仿竹, 靳佳川, 等. 小RNA 2'-O-甲基转移酶Henmt1在小鼠精子发生中的作用[J]. 南京医科大学学报(自然科学版), 2020,40:1263-1268.
  DAI X Y, WANG F Z, JIN J C, et al. Roles of small RNA 2'-O-methyltransferase Henmt1 during mouse spermatogenesis[J]. Journal of Nanjing Medicial University (Natural Sciences), 2020,40:1263-1268.
[10] BEGIK O, LUCAS M C, LIU H L, et al. Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures[J]. Genome Biol, 2020, 21(1): 97.
[11] LEE E, LOKMAN N A, OEHLER M K, et al. A comprehensive molecular and clinical analysis of the PiRNA pathway genes in ovarian cancer[J]. Cancers (Basel), 2020, 13(1): 4.
[12] HEMPFLING A L, LIM S L, ADELSON D L, et al. Expression patterns of HENMT1 and PIWIL1 in human testis: implications for transposon expression[J]. Reproduction, 2017, 154(4): 363-374.
[13] REYIMU A, XING F, ZHOU W B, et al. Screening of potential key genes in esophageal cancer based on RBP and expression verification of HENMT1[J]. Medicine (Baltimore), 2023, 102(49): e36544.
[14] ZHENG Y, MENG X W, YANG J P. Exploring potential regulatory anesthetic drugs based on RNA binding protein and constructing CESC prognosis model: a study based on TCGA database[J]. Front Surg, 2022, 9: 823566.
[15] FATTAHI S, AMJADI-MOHEB F, TABARIPOUR R, et al. PI3K/AKT/mTOR signaling in gastric cancer: epigenetics and beyond[J]. Life Sci, 2020, 262: 118513.
[16] ZHAO W D, ZHAO X H, XU M L, et al. Knockdown of LINC01279 suppresses gastric cancer proliferation and migration by inhibiting PI3K/Akt/mTOR signaling pathway[J]. J Oncol, 2022, 2022: 6228982.
[17] GU X J, LI Y J, WANG F, et al. miR-30e-3p inhibits gastric cancer development by negatively regulating THO complex 2 and PI3K/AKT/mTOR signaling[J]. World J Gastrointest Oncol, 2022, 14(11): 2170-2182.
[18] LI H, ZHAO S F, SHEN L W, et al. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer[J]. Aging (Albany NY), 2021, 13(10): 13626-13643.
[19] WANG N, DONG Q, ZHOU X N. LMO4 promotes the invasion and proliferation of gastric cancer by activating PI3K-Akt-mTOR signaling[J]. Am J Transl Res, 2019, 11(10): 6534-6543.
[20] HU F F, HE Z K, SUN C N, et al. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway[J]. Gene, 2019, 700: 96-104.
[21] BAGHERY SAGHCHY KHORASANI A, POURBAGHERI-SIGAROODI A, PIRSALEHI A, et al. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions[J]. Eur J Pharmacol, 2021, 898: 173983.
文章导航

/